Rhythm Pharmaceuticals (NasdaqGM:RYTM) Update / briefing Transcript

Rhythm Pharmaceuticals (NasdaqGM:RYTM) Update / briefing March 16, 2026 04:30 PM ET Company ParticipantsCorinne Johnson - VP of Equity ResearchDave Connolly - Head of Investor RelationsDavid Meeker - Chairman, President, and CEOLisa Walter - VP Biotech Equity ResearchTazeen Ahmad - Managing Director of US Equity ResearchNone - Company RepresentativeConference Call ParticipantsDerek Archila - Equity AnalystEvan Lang - AnalystJon Wolleben - Managing Director and Senior Equity Research AnalystPhil Nadeau - Man ...